Section of Pediatric Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, 48109-4211, USA.
J Physiol. 2013 Aug 1;591(15):3709-23. doi: 10.1113/jphysiol.2013.253518. Epub 2013 Jun 10.
Tumour necrosis factor-α (TNF-α) has been reported to play a central role in intestinal barrier dysfunction in many diseases; however, the precise role of the TNF-α receptors (TNFRs) has not been well defined using in vivo models. Our previous data showed that enteral nutrient deprivation or total parenteral nutrition (TPN) led to a loss of intestinal epithelial barrier function (EBF), with an associated upregulation of TNF-α and TNFR1. In this study, we hypothesized that TNF-α plays an important role in TPN-associated EBF dysfunction. Using a mouse TPN model, we explored the relative roles of TNFR1 vs. TNFR2 in mediating this barrier loss. C57/BL6 mice underwent intravenous cannulation and were given enteral nutrition or TPN for 7 days. Tumour necrosis factor-α receptor knockout (KO) mice, including TNFR1KO, TNFR2KO or TNFR1R2 double KO (DKO), were used. Outcomes included small intestine transepithelial resistance (TER) and tracer permeability, junctional protein zonula occludens-1, occludin, claudins and E-cadherin expression. In order to address the dependence of EBF on TNF-α further, exogenous TNF-α and pharmacological blockade of TNF-α (Etanercept) were also performed. Total parenteral nutrition led to a loss of EBF, and this was almost completely prevented in TNFR1R2DKO mice and partly prevented in TNFR1KO mice but not in TNFR2KO mice. The TPN-associated downregulation of junctional protein expression and junctional assembly was almost completely prevented in the TNFR1R2DKO group. Blockade of TNF-α also prevented dysfunction of the EBF and junctional protein losses in mice undergoing TPN. Administration of TPN upregulated the downstream nuclear factor-B and myosin light-chain kinase (MLCK) signalling, and these changes were almost completely prevented in TNFR1R2DKO mice, as well as with TNF-α blockade, but not in TNFR1KO or TNFR2KO TPN groups. Tumour necrosis factor-α is a critical factor for TPN-associated epithelial barrier dysfunction, and both TNFR1 and TNFR2 are involved in EBF loss. Nuclear factor-B and MLCK signalling appear to be important downstream mediators involved in this TNF-α signalling process.
肿瘤坏死因子-α(TNF-α)已被报道在许多疾病中在肠道屏障功能障碍中发挥核心作用;然而,在体内模型中,TNF-α受体(TNFRs)的确切作用尚未得到很好的定义。我们之前的数据表明,肠内营养剥夺或全胃肠外营养(TPN)导致肠上皮屏障功能(EBF)丧失,同时 TNF-α和 TNFR1 上调。在这项研究中,我们假设 TNF-α在 TPN 相关的 EBF 功能障碍中起重要作用。我们使用小鼠 TPN 模型,探讨了 TNFR1 与 TNFR2 在介导这种屏障丧失中的相对作用。C57/BL6 小鼠接受静脉置管,并接受肠内营养或 TPN 治疗 7 天。使用 TNF-α受体敲除(KO)小鼠,包括 TNFR1KO、TNFR2KO 或 TNFR1R2 双重 KO(DKO)。结果包括小肠跨上皮电阻(TER)和示踪剂通透性、连接蛋白紧密连接蛋白-1、occludin、claudin 和 E-钙粘蛋白表达。为了进一步探讨 EBF 对 TNF-α的依赖性,还进行了外源性 TNF-α和 TNF-α的药理学阻断(etanercept)。TPN 导致 EBF 丧失,在 TNFR1R2DKO 小鼠中几乎完全预防,在 TNFR1KO 小鼠中部分预防,但在 TNFR2KO 小鼠中不预防。TPN 相关的连接蛋白表达和连接组装下调在 TNFR1R2DKO 组几乎完全预防。TNF-α的阻断也预防了 TPN 小鼠 EBF 功能障碍和连接蛋白丢失。TPN 给药上调了下游核因子-B 和肌球蛋白轻链激酶(MLCK)信号,在 TNFR1R2DKO 小鼠中几乎完全预防,与 TNF-α阻断一样,但在 TNFR1KO 或 TNFR2KO TPN 组中没有预防。肿瘤坏死因子-α是 TPN 相关上皮屏障功能障碍的关键因素,TNFR1 和 TNFR2 均参与 EBF 丧失。核因子-B 和 MLCK 信号似乎是 TNF-α信号通路中的重要下游介质。